2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Sales - EUR | - | - | - | - | 2.383 | 5.683 | 2.533 | 1.064 | 483 | 237 |
Total Income - EUR | - | - | - | - | 2.383 | 23.641 | 7.962 | 8.123 | 10.143 | 8.691 |
Total Expenses - EUR | - | - | - | - | 1.254 | 5.745 | 6.572 | 5.938 | 6.432 | 8.965 |
Gross Profit/Loss - EUR | - | - | - | - | 1.129 | 17.896 | 1.390 | 2.185 | 3.710 | -275 |
Net Profit/Loss - EUR | - | - | - | - | 1.129 | 17.744 | 1.227 | 2.153 | 3.696 | -275 |
Employees | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Laurvetbio S.r.l.
See the company's note based on the submitted financial data, relative to the industry of which it is a part.
Check Financial Rating2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Fixed Assets | 799 | 3.836 | 6.745 | 10.472 | 14.318 | 0 | - | - | - | - |
Current Assets | - | - | - | - | 1.172 | 29.560 | 30.340 | 19.411 | 24.793 | 21.935 |
Inventories | - | - | - | - | 0 | 959 | 1.473 | 1.411 | 6.647 | 7.630 |
Receivables | - | - | - | - | 0 | 9.827 | 0 | 24 | 48 | 48 |
Cash | - | - | - | - | 1.172 | 18.773 | 28.867 | 17.976 | 18.098 | 14.257 |
Shareholders Funds | - | - | - | - | 1.172 | 18.893 | 19.762 | 11.804 | 15.536 | 15.215 |
Social Capital | - | - | - | - | 43 | 42 | 41 | 40 | 41 | 40 |
Debts | - | - | - | - | 0 | 839 | 1.235 | 378 | 404 | 1.653 |
Income in Advance | - | - | - | - | 0 | 24.146 | 19.816 | 13.974 | 12.688 | 5.867 |
Exchange rate - RON | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 | 4.4821 |
Main CAEN | "113 - 113" | |||||||||
CAEN Financial Year | 113 |
Subscriptions Financial Reports
You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.
Reports that can be accessed based on the subscription:
Get the contact details for any company and get in touch with it.